SHARE
 
Nasia Safdar, MD close
9zAGm11VBAE
Nasia Safdar, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Nasia Safdar, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Nasia Safdar has been the Medical Director of Infection Control at UW Hospital and Clinics since 2009. She came to Wisconsin in 1997 for her residency and fellowship. She is board certified in infectious disease and she focuses on healthcare-associated infections, particularly in the acute care setting. Dr. Safdar believes that many health care-associated infections can be prevented with adherence to known best practices. As medical director for the department of infection prevention, her job is to lead the department in its mission of reducing healthcare-associated infections by identifying, testing and implementing interventions that have benefit for reducing health care associated infections (HAI).

 

She is an associate professor of infectious diseases at the University of Wisconsin School of Medicine and Public Health and the Associate Chief of Staff for Research at the William S. Middleton VA Hospital. Her research includes the evaluation of novel and innovative strategies for prevention of HAI. She is currently leading the fecal bacteriotherapy program at UW Hospital and is the principal investigator of a current ongoing VA-funded trial of probiotics for reducing HAI.

Specialties

Infectious Diseases

Clinics

University Hospital
(608) 263-0946 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship Sir Ganga Ram Hospital, Lahore, Pakistan
Medical School Aga Khan University Medical College, Karachi, Pakistan

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Safdar is interested in examining the efficacy of novel interventions to reduce healthcare-associated infection such as the use of probiotics for reducing colonization by methicillin-resistant Staphylococcus aureus and Clostridium difficileand has ongoing trials in this area. 


PubMed Articles
Stathis C Victoria N Loomis K Nguyen SA Eggers M Septimus E Safdar N Review of the use of nasal and oral antiseptics during a global pandemic. Future Microbiol . 2021 Jan 19;
[PubMed ID: 33464122]
Alagoz O Sethi AK Patterson BW Churpek M Safdar N Effect of Timing of and Adherence to Social Distancing Measures on COVID-19 Burden in the United States : A Simulation Modeling Approach. Ann Intern Med . 2021 Jan;174(1):50-57
[PubMed ID: 33105091]
Knobloch MJ Musuuza JS McKinley L Zimbric ML Baubie K Hundt AS Carayon P Hagle M Pfeiffer CD Galea MD Crnich CJ Safdar N Implementing daily chlorhexidine gluconate (CHG) bathing in VA settings: The human factors engineering to prevent resistant organisms (HERO) project. Am J Infect Control . 2020 Dec 25;
[PubMed ID: 33359552]
Parmasad V Keating JA Carayon P Safdar N Physical distancing for care delivery in health care settings: Considerations and consequences. Am J Infect Control . 2020 Dec 24;
[PubMed ID: 33359551]
Pop-Vicas AE Keating JA Heise C Carayon P Safdar N Gaining momentum in colorectal surgical site infection reduction through a human factors engineering approach. Infect Control Hosp Epidemiol . 2020 Dec 7;:1-3
[PubMed ID: 33280622]
Pulia MS Wolf I Schwei RJ Chen D Lepak AJ Schulz LT Safdar N Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitonin. Infect Control Hosp Epidemiol . 2020 Nov 19;:1-3
[PubMed ID: 33208206]
Hammond EN Brys N Kates A Musuuza JS Haleem A Bentz ML Safdar N Nasal povidone-iodine implementation for preventing surgical site infections: Perspectives of surgical nurses. PLoS One . 2020;15(11):e0242217
[PubMed ID: 33211722]
Moreno GK Braun KM Riemersma KK Martin MA Halfmann PJ Crooks CM Prall T Baker D Baczenas JJ Heffron AS Ramuta M Khubbar M Weiler AM Accola MA Rehrauer WM O'Connor SL Safdar N Pepperell CS Dasu T Bhattacharyya S Kawaoka Y Koelle K O'Connor DH Friedrich TC Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread. Nat Commun . 2020 Nov 3;11(1):5558
[PubMed ID: 33144575]
Eggers S Gennings C Malecki KMC Safdar N Arora M Exposure to environmental chemical mixtures is associated with nasal colonization by Staphylococcus aureus: NHANES 2001-2004. Environ Res . 2020 Nov;190:109994
[PubMed ID: 32771801]
Scaria E Powell WR Birstler J Alagoz O Shirley D Kind AJH Safdar N Neighborhood disadvantage and 30-day readmission risk following Clostridioides difficile infection hospitalization. BMC Infect Dis . 2020 Oct 16;20(1):762
[PubMed ID: 33066737]
Keating JA McKinley L Safdar N Coronavirus disease 2019 (COVID-19) and antibiotic stewardship: Using a systems engineering approach to maintain patient safety. Infect Control Hosp Epidemiol . 2020 Oct 12;:1-3
[PubMed ID: 33040756]
Lepak AJ Shirley DK Buys A Stevens L Safdar N Implementation of infection control measures to prevent healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect Control Hosp Epidemiol . 2020 Oct 12;:1-4
[PubMed ID: 33040753]
Ramanathan S Suda KJ Fitzpatrick MA Guihan M Goedken CC Safdar N Evans M Jones M Pfeiffer CD Perencevich EN Rubin M Evans CT QUERI CARRIAGE Program. A survey of infection control strategies for carbapenem-resistant <i>Enterobacteriaceae</i> in Department of Veterans' Affairs facilities. Infect Control Hosp Epidemiol . 2020 Sep 22;:1-4
[PubMed ID: 32959749]
Lepak AJ Chen DJ Buys A Stevens L Safdar N Utility of Repeat Nasopharyngeal SARS-CoV-2 RT-PCR Testing and Refinement of Diagnostic Stewardship Strategies at a Tertiary Care Academic Center in a Low-Prevalence Area of the United States. Open Forum Infect Dis . 2020 Sep;7(9):ofaa388
[PubMed ID: 32964068]
Tischendorf J Brunner M Knobloch MJ Schulz L Barker A Wright MO Lepak A Safdar N Evaluation of a successful fluoroquinolone restriction intervention among high-risk patients: A mixed-methods study. PLoS One . 2020;15(8):e0237987
[PubMed ID: 32841259]
Rivera F Safdar N Ledeboer N Schaack G Chen DJ Munoz-Price LS Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin. Clin Infect Dis . 2020 Aug 19;
[PubMed ID: 32812030]
Barker AK Scaria E Safdar N Alagoz O Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection. JAMA Netw Open . 2020 Aug 3;3(8):e2012522
[PubMed ID: 32789514]
Pop-Vicas A Stern R Osman F Safdar N Variability in infection surveillance methods and impact on surgical site infection rates. Am J Infect Control . 2020 Jul 2;
[PubMed ID: 32622837]
Pop-Vicas AE Abad C Baubie K Osman F Heise C Safdar N Colorectal bundles for surgical site infection prevention: A systematic review and meta-analysis. Infect Control Hosp Epidemiol . 2020 Jul;41(7):805-812
[PubMed ID: 32389140]
Weiner S Schwartz A Altman L Ball S Bartle B Binns-Calvey A Chan C Falck-Ytter C Frenchman M Gee B Jackson JL Jordan N Kass B Kelly B Safdar N Scholcoff C Sharma G Weaver F Wopat M Evaluation of a Patient-Collected Audio Audit and Feedback Quality Improvement Program on Clinician Attention to Patient Life Context and Health Care Costs in the Veterans Affairs Health Care System. JAMA Netw Open . 2020 Jul 1;3(7):e209644
[PubMed ID: 32735338]